| Human natural killer cells: a unique innate immunoregulatory role for the CD56bright subset MA Cooper, TA Fehniger, SC Turner, KS Chen, BA Ghaheri, T Ghayur, ... Blood, The Journal of the American Society of Hematology 97 (10), 3146-3151, 2001 | 1935 | 2001 |
| Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor. WE Carson, JG Giri, MJ Lindemann, ML Linett, M Ahdieh, R Paxton, ... The Journal of experimental medicine 180 (4), 1395-1403, 1994 | 1365 | 1994 |
| Psychologic intervention improves survival for breast cancer patients: a randomized clinical trial BL Andersen, HC Yang, WB Farrar, DM Golden‐Kreutz, CF Emery, ... Cancer 113 (12), 3450-3458, 2008 | 634 | 2008 |
| Psychological, behavioral, and immune changes after a psychological intervention: a clinical trial BL Andersen, WB Farrar, DM Golden-Kreutz, R Glaser, CF Emery, ... Journal of clinical oncology 22 (17), 3570-3580, 2004 | 572 | 2004 |
| A potential role for interleukin-15 in the regulation of human natural killer cell survival. WE Carson, TA Fehniger, S Haldar, K Eckhert, MJ Lindemann, CF Lai, ... The Journal of clinical investigation 99 (5), 937-943, 1997 | 532 | 1997 |
| Pain, depression, and fatigue: loneliness as a longitudinal risk factor. LM Jaremka, RR Andridge, CP Fagundes, CM Alfano, SP Povoski, ... Health Psychology 33 (9), 948, 2014 | 442 | 2014 |
| Endogenous production of interleukin 15 by activated human monocytes is critical for optimal production of interferon-gamma by natural killer cells in vitro. WE Carson, ME Ross, RA Baiocchi, MJ Marien, N Boiani, K Grabstein, ... The Journal of clinical investigation 96 (6), 2578-2582, 1995 | 427 | 1995 |
| Cutaneous melanoma, version 2.2019, NCCN clinical practice guidelines in oncology DG Coit, JA Thompson, MR Albertini, C Barker, WE Carson, C Contreras, ... Journal of the National Comprehensive Cancer Network 17 (4), 367-402, 2019 | 417 | 2019 |
| Myeloid derived suppressor cells–a new therapeutic target in the treatment of cancer R Wesolowski, J Markowitz, WE Carson Journal for immunotherapy of cancer 1, 1-11, 2013 | 361 | 2013 |
| Flt3 Ligand Promotes the Generation of a Distinct CD34+Human Natural Killer Cell Progenitor That Responds to Interleukin-15 H Yu, TA Fehniger, P Fuchshuber, KS Thiel, E Vivier, WE Carson, ... Blood, The Journal of the American Society of Hematology 92 (10), 3647-3657, 1998 | 296 | 1998 |
| Systemic delivery of anti-miRNA for suppression of triple negative breast cancer utilizing RNA nanotechnology D Shu, H Li, Y Shu, G Xiong, WE Carson III, F Haque, R Xu, P Guo ACS nano 9 (10), 9731-9740, 2015 | 285 | 2015 |
| Distress reduction from a psychological intervention contributes to improved health for cancer patients BL Andersen, WB Farrar, D Golden-Kreutz, CF Emery, R Glaser, ... Brain, behavior, and immunity 21 (7), 953-961, 2007 | 276 | 2007 |
| IL-12 enhances the natural killer cell cytokine response to Ab-coated tumor cells R Parihar, J Dierksheide, Y Hu, WE Carson The Journal of clinical investigation 110 (7), 983-992, 2002 | 264 | 2002 |
| The functional characterization of interleukin-10 receptor expression on human natural killer cells WE Carson, MJ Lindemann, R Baiocchi, M Linett, JC Tan, CC Chou, ... | 260 | 1995 |
| Melanoma, version 2.2016, NCCN clinical practice guidelines in oncology DG Coit, JA Thompson, A Algazi, R Andtbacka, CK Bichakjian, ... Journal of the National Comprehensive Cancer Network 14 (4), 450-473, 2016 | 258 | 2016 |
| Modulation of the tumor microenvironment and inhibition of EGF/EGFR pathway: Novel anti-tumor mechanisms of Cannabidiol in breast cancer M Elbaz, MW Nasser, J Ravi, NA Wani, DK Ahirwar, H Zhao, S Oghumu, ... Molecular oncology 9 (4), 906-919, 2015 | 251 | 2015 |
| Sentinel node biopsy in breast cancer JM Barnwell, MA Arredondo, D Kollmorgen, JF Gibbs, D Lamonica, ... Annals of Surgical Oncology 5, 126-130, 1998 | 241 | 1998 |
| Social support predicts inflammation, pain, and depressive symptoms: longitudinal relationships among breast cancer survivors S Hughes, LM Jaremka, CM Alfano, R Glaser, SP Povoski, AM Lipari, ... Psychoneuroendocrinology 42, 38-44, 2014 | 240 | 2014 |
| Myeloid-derived suppressor cell inhibition of the IFN response in tumor-bearing mice BL Mundy-Bosse, GB Lesinski, AC Jaime-Ramirez, K Benninger, M Khan, ... Cancer research 71 (15), 5101-5110, 2011 | 238 | 2011 |
| Signaling pathways involved in MDSC regulation P Trikha, WE Carson III Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1846 (1), 55-65, 2014 | 231 | 2014 |
